Eran Ovadya, Chief Financial Officer of NurExone stated, “The ISCT 2025 conference is a key opportunity to showcase our advances and to expand our U.S. presence. As we grow Exo-Top and pursue U.S.
Tokio Marine is a strong buy! Emerging market growth, resilient profitability, and the 'Re-New' initiative drive its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback